Shionogi’s cefiderocol shows improved outcomes with early use in treating gram-negative infections:…
PROVE study reveals significantly improved outcomes with early use of cefiderocol in treating serious gram-negative infections,…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
antimicrobial resistance (AMR)
Oxford Nanopore and BRIC Institutes sign Letters of Intent to establish two Centres of Excellence in…
Collaborations with BRIC-CDFD and BRIC-NIBMG to support rare disease, cancer, and infectious disease research using Oxford…
Venus Remedies partners with Infex Therapeutics for clinical development of MET-X in India
On an exclusive licensing agreement, Venus Remedies will lead clinical trials and commercialisation of MET-X to combat…
Responsible antibiotic use: How the industry can lead the way for evidence-backed guidelines
Devvesh P Srivastav outlines the critical role of the industry in combating antimicrobial resistance through evidence-based…